SEMINOMA
Clinical trials for SEMINOMA explained in plain language.
Never miss a new study
Get alerted when new SEMINOMA trials appear
Sign up with your email to follow new studies for SEMINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Robot surgery could spare testicular cancer patients from chemotherapy
Disease control Recruiting nowThis study tests a robot-assisted surgery to remove lymph nodes in men with early-stage testicular cancer (seminoma) that has spread to nearby nodes. The goal is to find better ways to predict if the cancer will come back, so some patients may avoid chemotherapy and its long-term…
Matched conditions: SEMINOMA
Phase: PHASE2 • Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Robot dye test could spare testicular cancer patients unnecessary treatment
Diagnosis Recruiting nowThis study tests a new robot-assisted technique that uses a special dye (ICG) to find if testicular cancer has spread to nearby lymph nodes. Current methods often miss small cancer deposits, leading to either undertreatment or overtreatment. The goal is to see if this approach ca…
Matched conditions: SEMINOMA
Phase: NA • Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Diagnosis
Last updated May 20, 2026 11:56 UTC
-
Testicular cancer: which treatment spares quality of life?
Symptom relief Recruiting nowThis study looks at how different treatments affect quality of life in men with good-prognosis metastatic testicular cancer. Some will have surgery (RPLND) and others will get chemotherapy. The goal is to see which approach causes fewer side effects and better long-term well-bein…
Matched conditions: SEMINOMA
Phase: NA • Sponsor: Sahlgrenska University Hospital • Aim: Symptom relief
Last updated May 26, 2026 04:50 UTC
-
Testicular cancer treatment may be reduced without harm, new study hopes
Knowledge-focused Recruiting nowThis study is testing whether men with stage II seminoma testicular cancer can receive less intensive treatment without harming their health. Researchers will track 30 patients in two UK hospitals to see if they are willing to join the study, how their cancer responds, and how th…
Matched conditions: SEMINOMA
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC